The pharma company's newer immunology drugs, Skyrizi and Rinvoq, have delivered robust sales growth that's proving to be the ...

Rinvoq will have to come up against Pfizer’s prospective and Incyte’s approved JAK inhibitors in the NSV indication.

Dandruff doesn't directly cause hair loss, but it can lead to it. Certain conditions that cause flakes and hair loss include ...

In two replicate Phase 3 studies, upadacitinib (RINVOQ ® ) achieved the co-primary endpoints of 50% reduction in Total Vitiligo Area Scoring Index (T-VASI 50) from baseline and 75% reduction in Facial ...

Discover how a common sweetener is being used to supercharge a leading hair loss treatment in a recent research.

ISHRS Hosts Live Surgery Workshop in Bucharest, Romania, November 7-9, 2025, focusing on hair repair CHICAGO, Oct. 29, 2025 ...

This article was reviewed by Knox Beasley, MD. Nioxin vs. Rogaine: Which is Better for Hair Loss? Finding the right hair growth treatment can be a … ...

THIS AUTUMN, Paris, France, hosted the 34ᵗʰ annual European Academy of Dermatology and Venereology (EADV) Congress.

After whittling down 12 bakers over the course of 10 episodes, the Channel 4 baking competition show has declared their series 16 winner.

Glucagon-like peptide-1 receptor agonists (GLP-1RA) are widely prescribed for Type 2 diabetes and obesity owing to their ...

Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition that affects around 14,000 ...